BioSpace News Archive

Stratus Pharmaceuticals, Inc. and Tarmac Products, Inc. are pleased to announce that the U.S. Food and Drug Administration (FDA) inspected and approved its Miami Gardens manufacturing facility to be GMP (Good Manufacturing Practices) compliant.

RealSelf announced Ms. Tanja Omeze has been named its first chief marketing officer.

TCR2 Therapeutics Inc., an immuno-oncology company pioneering a novel class of T cell receptor (TCR)-based cellular therapies for solid tumors and blood cancers, announced today that new preclinical data on its TRuC™ platform and its lead solid tumor program TC-210 will be presented at the American Association for Cancer Research (AACR) 2018 Annual Meeting to be held April 14-18, 2018 in Chicago, IL.

The agency is leveraging new tools and policies to advance the creation of innovative genetic and genomic-based tests and help ensure the validity of their results

Jin Wang, Ph.D. named Site Head/General Manager

Ametros has announced the hire of Chris Lagnese and Phyllis Ramondetta, RN, BS, CCM, CLCP, MSCC, CLNC, to lead a new service offering, Health Navigator, within Ametros.

Endotronix, Inc., a medical technology company providing device and digital health solutions for heart failure management, today announced the appointment of seasoned life sciences executive and entrepreneur John Flavin as Chief Financial Officer.

Earlier this week, Coral Springs, Fla.-based P2P Staffing Corporation agreed to sell their MedPartners HIM business unit to AMN Healthcare, Inc. for $195 million, with the potential for an additional $20 million based on future performance. The deal closed on Monday, April 9, 2018.

-- Scientists require human biofluid, tissue and cell specimens that meet precise requirements to advance biomedical research, but often have difficulty locating the specific patient samples they need. -- iSpecimen works with laboratories to compliantly aggregate for researchers remnant human samples that would otherwise be discarded.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 first quarter financial results for Friday, May 4 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.